Product
ENT-01
Aliases
Active Investigational Treatment ENT-01
4 clinical trials
4 indications
Indication
Parkinson's DiseaseIndication
ConstipationIndication
Parkinson's diseaseIndication
DementiaClinical trial
A Multi-Center, Single-Dose, Multiple-Dose, Double-Blind, Placebo-Controlled Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Orally Administered ENT-01 for the Treatment of Parkinson's Disease Related ConstipationStatus: Completed, Estimated PCD: 2018-04-25
Clinical trial
A Multicenter, Non-Randomized, Open-Label Study to Evaluate the Safety and Efficacy of Orally Administered ENT-01 in Improving Constipation and Neurologic Symptoms in Patients With Parkinson's Disease and Constipation Over a 14-week PeriodStatus: Terminated, Estimated PCD: 2022-02-17
Clinical trial
A Multicenter, Open Label Study to Evaluate Tolerability and Efficacy of Orally Administered ENT-01 for the Treatment of Parkinson's Disease Dementia.Status: Withdrawn, Estimated PCD: 2025-06-15
Clinical trial
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study to Evaluate Safety, Tolerability and Efficacy of Orally Administered ENT-01 for the Treatment of Parkinson's Disease-Related Constipation (KARMET)Status: Completed, Estimated PCD: 2021-12-14